Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES 简体中文 中文 हिन्दी HI
Sign Up
Log in
N

Neuraxis Inc
AMEX:NRXS

Watchlist Manager
Neuraxis Inc
AMEX:NRXS
Watchlist
Price: 7.705 USD -0.45% Market Closed
Market Cap: $95.4m
Write Note Create Alert Ask AI

Intrinsic Value

Not Available for NRXS

There is not enough data to reliably calculate the intrinsic value for Neuraxis Inc.

Do our valuations actually work? See backtest results .

Alternatives to NRXS

Fundamental Analysis

What Neuraxis Does

Health Care

NeurAxis, Inc. engages in the provision of neuromodulation therapies to address chronic and debilitating conditions in children. The company is headquartered in Carmel, Indiana and currently employs 24 full-time employees. The company went IPO on 2023-08-09. The firm is focused on developing neuromodulation therapies for chronic and debilitating conditions in gastrointestinal (GI) digestive system, specifically from disorders of the gut-brain interaction (DGBIs) in pediatrics and adults.

Headquarters
United States of America US
Employees
24
IPO date
Aug 9, 2023
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Neuraxis Inc

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

Ownership

NRXS Insider Trading
Buy and sell transactions by insiders

Continue NRXS Research

Summary
NRXS intrinsic value, competitors valuation, and company profile.
DCF Valuation
NRXS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NRXS stock valuation using valuation multiples.
Wall St Estimates
NRXS price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financial Statements
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NRXS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financial Statements
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join 361,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.